Idiopathic acquired sideroblastic anaemia is a disorder of haematopoietic stem cell differentiation and proliferation, probably representing the emergence of an abnormal haemopoietic clone. ' While patients with this disease, usually elderly, often die of unrelated causes, this disease often undergoes transformation to acute leukaemia.2-7 Transformation to acute myelofibrosis, however, is rare. [8] [9] [10] We report a patient with idiopathic acquired sideroblastic anaemia who developed acute myelofibrosis." In addition to the characteristic ring sideroblasts and erythroid hyperplasia, this patient's bone marrow showed atypical megakaryocytic proliferation before progression to acute myelofibrosis. was hypercellular with hyperplastic erythropoiesis, mild dysplastic changes, and numerous ring sideroblasts (Fig. 1) . Granulopoiesis was unremarkable. Megakaryocytes were clearly increased in number with more than normal variation in size, nuclear form, ploidy, and nuclear to cytoplasmic ratio. Idiopathic acquired sideroblastic anaemia was diagnosed.
The patient was given blood transfusion, but otherwise his clinical and laboratory findings did not change appreciably until October 1982, when neutropenia, increasing thrombocytopenia, and palpable splenomegaly were found. By January 1983, thrombocytopenia was severe (platelet count 20 x 109/l) and the blood film became leukoerythroblastic with the presence of myelocytes (0.4 x 109/l) and occasional blast forms (haemoglobin concentration 7-7 g/dl, white cell count 2-6 x 109/l). Attempts at bone marrow aspiration yielded a "dry tap." Bone marrow biopsy showed a hypercellular marrow with, as before, atypical megakaryocytic proliferation now accompanied by increased reticulin and collagen fibres (Fig. 2) granulocytic, monocytic, and platelet lineages derive from a common pluripotent stem cell, marrow fibroblasts are probably of separate origin. '3 It is rare for idiopathic acquired sideroblastic anaemia to. progress to acute or malignant myelofibrosis. Lewis and Szur first identified malignant myelofibrosis as a separate entity in 1963." Yeung and Trowbridge'°described the first example of idiopathic acquired sideroblastic anaemia transforming to acute myelofibrosis in 1977. A further case was identified by Butler et aP8 which showed atypical megakaryocytic proliferation, and Lukowicz et al9 reported two patients with idiopathic acquired sideroblastic anaemia who had thrombocytosis associated with myelofibrosis.
In five cases of de novo acute myelofibrosis blast cells in the peripheral blood were characterised as being of megakaryocytic origin using the platelet peroxidase reaction. '5 16 Bain et al'5 postulated that acute myelofibrosis is secondary to the megakaryocytic proliferation. In most cases of idiopathic acquired sideroblastic anaemia transforming to acute myelofibrosis there has been evidence of 1034 megakaryocytic hyperplasia. Platelet derived growth factor has been suggested as having a role in the pathogenesis of myelofibrosis. Defective megakaryoctic maturation results in the intramedullary destruction of developing megakaryocytes, and it has been suggested that megakaryocytic cytoplasmic contents are released into the marrow, including megakaryocytic platelet derived growth factor and factor 4.5 Platelet derived growth factor stimulates fibroblasts to proliferate and secrete collagen. Factor 4, contained in platelet alpha granules, causes inhibition of granulocyte and fibroblast collagenase, which normally degrades bone marrow collagen and reticulin fibres.'7 It is suggested that as a result of the action of these two factors, collagen and reticulin fibres are increased, resulting in acute myelofibrosis. '7 The presence of megakaryocytic proliferation in sideroblastic anaemia may have prognostic potential, indicating the likelihood of subsequent transformation into acute myelofibrosis and therefore predicting a poor prognosis. 
